National Immunization Strategy. Advocacy to seek continued funding in vaccines.
Legislative Proposal, Bill or Resolution, Regulation
Patent Act as it relates to the implementation of the Comprehensive Economic Trade Agreement (CETA) and its Intellectual property protection provisions.
The international trade negotiations under the Tans-Pacific Partnership (TPP) as it relates to potential legislative or regulatory changes of Canada's intellectual property regime for pharmaceutical products (Patent Act).
Policies or Program
Canadian Agency for Drugs and Technologies in Health (CADTH)/Common Drug Review as it relates to reimbursement recommendations decision-making process and framework.
Federal Public Drug Plans, with respect to the reimbursement of therapeutic products for Federal plan beneficiaries
Science and Technology Strategy, Advantage Canada or any Government policy or program initiatives to help support more Research and Development conducted in Canada, advocate for the development of a coordinated life science strategy
The Public Works and Government Services Integrity Framework as it relates to Canada's Vaccine Supply.
Policies or Program, Regulation
Subsequent Entry Biologics (SEBs) and Orphan Drugs framework: seeking an approval framework supported and protected by Regulations in harmonization with other developed countries
Regulation
Patented Medicine Prices Review Board (PMPRB) Regulations as it relates to reporting requirements and pricing guidelines.
Patented Medicines (Notice of Compliance) Regulations as it relates to the regulation of intellectual property for therapeutic products.
The implementation of all the upcoming regulations related to Bill C-17, an Act to Amend the Food and Drugs Act.